A pathology error lawsuit is a legal claim brought by patients who have suffered harm due to mistakes made by pathologists or pathology laboratories. These errors can include misdiagnosis of cancer, contamination of tissue samples, incorrect interpretation of biopsy results, delayed reporting of critical findings, or failure to communicate test results to treating physicians. Unlike many medical malpractice claims that result from surgical mistakes or medication errors, pathology errors occur in the laboratory setting where trained professionals are tasked with examining tissue samples, blood work, and other specimens to identify disease.
The financial impact of these cases can be substantial. In 2025, a Philadelphia jury awarded $35 million against Penn Medicine and Main Line Health in a case where contaminated biopsy slides containing another patient’s DNA led to a false endometrial cancer diagnosis and an unnecessary hysterectomy. This verdict underscores how pathology errors are not merely technical mistakes—they directly alter the course of a patient’s life, leading to unnecessary surgeries, delayed treatment for actual disease, or years of emotional distress based on incorrect diagnoses.
Table of Contents
- WHAT ARE THE MOST COMMON TYPES OF PATHOLOGY ERRORS?
- MAJOR SETTLEMENTS AND VERDICTS IN PATHOLOGY ERROR LITIGATION
- WHEN PATHOLOGY ERRORS INTERSECT WITH FRAUD: THE KICKBACK SETTLEMENT
- PATHOLOGY DATA BREACHES AND PATIENT PRIVACY IMPACTS
- INSTITUTIONAL FAILURES AND SYSTEM-LEVEL PATHOLOGY ERRORS
- IDENTIFYING IF YOU HAVE A PATHOLOGY ERROR CLAIM
- THE FUTURE OF PATHOLOGY ERROR PREVENTION AND LITIGATION TRENDS
- Conclusion
WHAT ARE THE MOST COMMON TYPES OF PATHOLOGY ERRORS?
Pathology errors fall into several distinct categories, each with serious consequences for patients. The most damaging errors involve misdiagnosis, where a pathologist fails to identify cancer, miscategorizes the stage of a disease, or renders an interpretation that contradicts clinical evidence. Another common category involves specimen handling errors—contamination, mislabeling, or loss of tissue samples—which can compromise the integrity of diagnostic results. Communication failures represent a third major category, where a pathology report is completed correctly but never reaches the treating physician, is misplaced, or is delivered with inadequate urgency given the findings. The Penn Medicine case illustrates how contamination errors can unfold. A patient’s biopsy showed endometrial cancer based on the pathology report, leading to a hysterectomy. However, the slides were later found to contain DNA from another patient, meaning the diagnosis was not based on the patient’s actual tissue.
She did not actually have endometrial cancer. The contamination created a false diagnosis, resulting in surgical harm and the removal of healthy reproductive organs. This type of error is particularly insidious because both the pathologist and the patient may be confident in the diagnosis—the error is not obvious until additional testing or investigation reveals the truth. Delayed diagnosis cases create a different harm profile. A 2025 settlement of $5.25 million resolved a case where pathology reports identified aggressive testicular cancer, but the hospital and treating surgeon never received proper notification of these findings. The delay in communicating critical results meant the patient’s cancer progressed without timely intervention. The communication failure included a faxed report that never reached its destination, leaving the patient without prompt treatment.
MAJOR SETTLEMENTS AND VERDICTS IN PATHOLOGY ERROR LITIGATION
The pathology error cases reaching settlement or verdict in recent years reveal the serious liability exposure facing medical institutions and pathology services. The $35 million Philadelphia verdict in 2025 represents one of the largest jury awards for this category of error. The jury found Penn Medicine 35 percent liable, resulting in a $12.25 million judgment against that institution alone. This verdict establishes a significant benchmark for pathology contamination cases and signals that juries will award substantial damages when a pathology error leads to unnecessary surgery and emotional harm. The $5.25 million settlement for delayed cancer diagnosis reflects the damages associated with negligent communication of pathology results. Even when the pathology interpretation is correct, failure to transmit results in a timely manner constitutes actionable negligence.
The fax transmission failure in that case—a seemingly outdated technology in modern medicine—became the critical point of failure. This settlement demonstrates that courts recognize both the direct harm (disease progression due to delayed treatment) and the institutional negligence (outdated communication systems) as compensable injuries. A limitation in pursuing pathology error claims is that proving causation can be complex. Even when a pathology error is established, the patient must prove that the error directly caused harm and that this harm would not have occurred but for the mistake. If a patient with a delayed cancer diagnosis eventually receives treatment and achieves full remission, damages calculations become more difficult. Courts look at what would have happened had the diagnosis been timely—would earlier treatment have improved outcomes, reduced suffering, or extended survival? These questions require expert testimony and can lengthen litigation.
WHEN PATHOLOGY ERRORS INTERSECT WITH FRAUD: THE KICKBACK SETTLEMENT
Not all pathology error litigation involves diagnostic mistakes. In 2025, Atlanta Gastroenterology Associates agreed to pay $4.75 million to settle False Claims Act violations involving kickbacks paid for pathology service referrals. In this case, the pathology errors were tied to a systemic problem: the practice was performing unnecessary gastrointestinal pathology services in exchange for financial incentives, rather than based on clinical need.
This type of case reveals how pathology errors can stem from economic pressure and misaligned incentives. When a laboratory or pathology service is compensated for volume rather than accuracy, there is a perverse motivation to find disease, order additional tests, or expand the scope of pathology services beyond what clinical judgment supports. Patients may undergo unnecessary biopsies or have tissue samples processed and interpreted with less rigor than would occur in a properly incentivized system. The Atlanta settlement serves as a warning that compliance in pathology services requires not just technical competence but also ethical structuring of financial relationships between referring physicians and pathology providers.
PATHOLOGY DATA BREACHES AND PATIENT PRIVACY IMPACTS
In addition to diagnostic errors and malpractice claims, pathology services have become the target of cybersecurity breaches affecting thousands of patients’ sensitive medical information. Summit Pathology experienced a significant data breach first identified on April 18, 2024. The breach exposed patient medical records and personal information, prompting a class action lawsuit brought by affected patients for the company’s failure to protect and properly notify individuals of the exposure. Shortly after, Keys Pathology Associates suffered a security breach through a third-party vendor, Genesis Billing Services, around May 20, 2025. Pathology companies maintain enormous repositories of patient data—not just biopsy results but also demographic information, insurance details, and genetic information in some cases. When these breaches occur, patients have limited remedies.
Most data breach settlements provide free credit monitoring for a limited period, but the underlying harm—the exposure of deeply personal medical information—cannot be undone. Patients affected by pathology data breaches often have little recourse beyond class action settlements, which typically provide modest compensation per affected individual. A key limitation in data breach litigation is that many settlements do not acknowledge fault or wrongdoing. Companies may agree to pay compensation while denying liability. Additionally, the notice period for data breaches can be substantial, sometimes months after the breach occurs. Patients may have unknowingly had their information exposed for an extended period before receiving notification.
INSTITUTIONAL FAILURES AND SYSTEM-LEVEL PATHOLOGY ERRORS
While individual pathologist errors do occur, many significant pathology cases reveal broader institutional failures. The Penn Medicine case involved not just a single contaminated slide but a systemic failure to prevent cross-contamination in the laboratory. The delayed cancer diagnosis case at the other institution involved outdated communication systems and lack of redundancy in critical result reporting. These cases illustrate that preventing pathology errors requires institutional commitment to quality control, standard operating procedures, and continuous monitoring.
The College of American Pathologists (CAP) has published comprehensive guidelines for interpretive diagnostic error reduction in surgical pathology and cytology. These guidelines recommend specific practices: second reviews for critical diagnoses, tissue image documentation, clear communication protocols for urgent findings, and regular training. However, adherence to CAP guidelines is voluntary unless accreditation is required by a specific state or health system. A limitation is that many smaller pathology laboratories may lack the resources to implement all recommended quality measures, creating a two-tiered system where well-funded institutions maintain higher quality standards than smaller or under-resourced services.
IDENTIFYING IF YOU HAVE A PATHOLOGY ERROR CLAIM
Patients who suspect they have been harmed by a pathology error should take specific steps to obtain records and expert evaluation. Request your pathology reports and tissue slides from the laboratory or hospital where the testing was performed. If you received a diagnosis that was later contradicted or revised, or if your diagnosis seems inconsistent with your clinical presentation, request an independent second opinion from another pathologist. Document all communications (or lack thereof) regarding your pathology results, including dates when you were notified of results and when your treating physician claimed to have received reports.
Expert review is critical before filing a claim. You will need a qualified pathologist willing to review your case and testify that the original pathologist’s interpretation fell below the standard of care. This expert report serves as the foundation for your claim. Additionally, you should gather medical records showing how the pathology error affected your treatment, including any unnecessary surgeries, delayed diagnoses, or additional suffering.
THE FUTURE OF PATHOLOGY ERROR PREVENTION AND LITIGATION TRENDS
As artificial intelligence and digital pathology tools become more prevalent, the landscape of pathology practice is shifting. Whole-slide imaging and AI-assisted diagnostics promise to reduce interpretive errors by allowing multiple pathologists to review complex cases simultaneously and by providing computer-generated assistance in identifying suspicious areas.
However, these new technologies also introduce new potential points of failure, including software errors, inadequate validation of AI tools, and over-reliance on automation. Litigation trends suggest that courts are increasingly willing to hold pathology services to higher standards, particularly when institutional failures are evident. The multi-million-dollar verdicts and settlements in recent years indicate that juries and judges recognize the profound harm caused by pathology errors—not merely as diagnostic mistakes but as events that alter the trajectory of patients’ lives, leading to unnecessary medical interventions, delayed treatment, and psychological trauma.
Conclusion
Pathology error lawsuits represent a critical area of medical malpractice litigation where diagnostic mistakes, communication failures, and institutional negligence can cause substantial harm to patients. The recent major verdicts and settlements—including the $35 million Penn Medicine case, the $5.25 million delayed cancer diagnosis settlement, and the $4.75 million kickback fraud case—demonstrate that courts recognize the serious consequences of pathology errors and are willing to award significant damages. These cases also reveal that pathology errors often result not from isolated mistakes but from systemic failures in laboratory practices, communication systems, and institutional oversight.
If you believe you have been harmed by a pathology error, the first step is to obtain your complete medical records and request an independent pathology review. An experienced medical malpractice attorney can help you determine whether your case has merit and guide you through the claims process. Given the complexity of proving pathology errors and establishing causation, working with qualified legal counsel early in the process is essential.